Redeye: FlexQube - 2023 – the year of the eQart Navigator

Redeye updates its estimates following FlexQube’s Q4 report, which posted better sales and EBITDA than expected, although order intake was relatively soft. Market activity is still high, however, which FlexQube sees in its price quotation levels (both in terms of volume and value). We choose to be cautious in the near term on the back of the order intake but remain very optimistic about H2 when the eQart Navigator hopefully can start generating sales following its launch during the year.

Read more and download the Research Update.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/

Attachments

FlexQube - 2023 – the year of the eQart Navigator